RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Cryptos Brace For Fed Review Amidst Rate Hike Uncertainty
  2. Barnes & Noble Education Rallies On Increased Sales In Q1
  3. World Markets Cheer The Fall In U.S. CPI
  4. Can Next Bitcoin Halving Push BTC Price To $148,000 By July 2025? Pantera Capital Thinks So
  5. Cryptos Subdued Ahead Of Earnings Updates From Wall Street’s Tech Space